Paul, a liver cancer survivor, and his wife Emma share their journey of recovery, caregiving and finding balance in life ...

Objective response at week 25 was 54% with pimicotinib versus 3% with placebo, supporting robust antitumor activity in unresectable TGCT. Patient-reported endpoints showed meaningful improvements in ...

Top experts share the latest bladder, kidney and prostate cancer advances from the 2026 ASCO GU Symposium, highlighting patient impact. At the 2026 ASCO GU meeting, experts gathered to share the ...

Rosemary Carrera discusses her breast cancer journey, mastectomy and the personal decision to remove her implants at the ...

Advocate Rosemary Carrera discusses her breast cancer journey, mastectomy and the personal decision to remove her implants at the Miami Breast Cancer Conference.

NCCN now includes Anktiva plus BCG for BCG-unresponsive papillary-only NMIBC, acknowledging an unmet need in patients without ...

Earlier-line bispecific therapy leverages lower disease refractoriness to drive deeper, more durable responses than typically ...

I was participating in a Drumming Clinical Study, which I really enjoyed. And I was so disappointed that I was unable to ...

In this segment, Dr. Gregory Vidal discusses how common metastatic breast cancer is and explains how it may develop over time ...

Broad endorsement for insurance-covered blood-based CRC screening (92%) suggests payer policy could materially influence ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program ...

For many, a stage 4 breast cancer diagnosis can feels scary, but Casey Liening is rewriting that narrative. After a two-year ...